Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 8/20 | 0.44 |
| ▸ | CCNT1 | O60563 | 7/20 | 0.44 |
| ▸ | CDK2 | P24941 | 3/20 | 0.44 |
| ▸ | CDK8 | P49336 | 3/20 | 0.44 |
| ▸ | CCNC | P24863 | 2/20 | 0.44 |
| ▸ | CDK7 | P50613 | 2/20 | 0.44 |
| ▸ | CCNH | P51946 | 2/20 | 0.44 |
| ▸ | MNAT1 | P51948 | 1/20 | 0.44 |
| ▸ | RET | P07949 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.40 |
| ▸ | GABBR2 | O75899 | 5/20 | 0.39 |
| ▸ | GABBR1 | Q9UBS5 | 5/20 | 0.39 |
| ▸ | CCND3 | P30281 | 3/20 | 0.36 |
| ▸ | CDK6 | Q00534 | 3/20 | 0.36 |
| ▸ | CDK4 | P11802 | 3/20 | 0.36 |
| ▸ | CCND1 | P24385 | 2/20 | 0.36 |
| ▸ | CDK1 | P06493 | 2/20 | 0.35 |
| ▸ | CCNK | O75909 | 1/20 | 0.34 |
| ▸ | CDK14 | O94921 | 1/20 | 0.34 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26585468 | 0.92 | CDK9 (0.50) | CDK9CCNT1CDK2CDK8CCNC | |
| SCHEMBL30893148 | 0.92 | CDK9 (0.50) | CDK9CCNT1CDK2CDK8CCNC | |
| SCHEMBL26127752 | 0.92 | CDK9 (0.50) | CDK9CCNT1CDK2CDK8CCNC | |
| SCHEMBL27214093 | 0.80 | CDK9 (0.65) | CDK9CCNT1CDK2CDK8CCNC | |
| SCHEMBL26585433 | 0.80 | CDK9 (0.65) | CDK9CCNT1CDK2CDK8CCNC | |
| SCHEMBL30603718 | 0.80 | CDK9 (0.65) | CDK9CCNT1CDK2CDK8CCNC | |
| SCHEMBL26585470 | 0.80 | CDK9 (0.51) | CDK9CCNT1CDK2CDK8CCNC | |
| SCHEMBL27214088 | 0.80 | CDK9 (0.51) | CDK9CCNT1CDK2CDK8CCNC | |
| SCHEMBL30893145 | 0.80 | CDK9 (0.51) | CDK9CCNT1CDK2CDK8CCNC | |
| SCHEMBL27214094 | 0.79 | CDK9 (0.52) | CDK9CCNT1CDK2CDK8CCNC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4504709-A1 | CDK9 INHIBITORS | Biolexis Therapeutics, Inc. (US) | 2025-02-12 | — | — | EP | disclosed |
| CN-119137103-A | CDK9 inhibitors | 拜奥列司治疗有限公司 | 2024-12-13 | — | — | CN | disclosed |
| US-20240150322-A1 | CDK9 Inhibitors | BAERENKRAFT THERAPEUTICS, LLC | 2024-05-09 | — | — | US | disclosed |
| WO-2023196518-A1 | CDK9 INHIBITORS | Biolexis Therapeutics, Inc. (US) | 2023-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150322-A1 | CDK9 Inhibitors | CDK9, CDK19, CDK1 | CDK9 1/4885CCNT1 40/4885CDK2 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.